Introduction and objectives: Recurrent cirrhosis complicates 10-30% of Liver transplants (LT) and can lead to consideration for re-transplantation. We evaluated the trajectories of relisted versus primary listed patients on the waitlist using a competing risk framework.Materials and methods: We retrospectively examined 1,912 patients listed for LT at our centre between from 2012 to 2020. Cox proportional hazard models were used to assess overall survival (OS) by listing type and competing risk analysis Fine-Gray models were used to assess cumulative incidence of transplant by listing type.Results: 1,731 patients were included (104 relisted). 44.2% of relisted patients received exception points vs. 19.8% of primary listed patients (p<0.001). Patients relisted without exceptions, representing those with graft cirrhosis, had the worst OS (HR: 4.17, 95%CI 2.63 - 6.67, p=<0.0001) and lowest instantaneous rate of transplant (HR: 0.56, 95%CI 0.38 - 0.83, p=0.006) than primary listed with exception points. On multivariate analysis listing type, height, bilirubin and INR were associated with cumulative incidence of transplant, while listing type, bilirubin, INR, sodium, creatinine were associated with OS. Within relisted patients, there was a trend towards higher mortality (HR: 1.79, 95%CI 0.91 - 3.52, p=0.08) and low transplant incidence (HR: 0.51, 95%CI 0.22 - 1.15, p=0.07) for graft cirrhosis vs other relisting indications.Conclusions: Patients relisted for LT are carefully curated and comprise a minority of the waitlist population. Despite their younger age, they have worse liver/kidney function, poor waitlist survival, and decreased transplant incidence suggesting the need for early relisting, while considering standardized exception points.(c) 2023 Fundacion Clinica Medica Sur, A.C. Published by Elsevier Espana, S.L.U.This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
机构:
Univ Hlth Network, Toronto Gen Hosp, Dept Surg, Multi Organ Transplant Program, Toronto, ON, CanadaUniv Hlth Network, Toronto Gen Hosp, Dept Surg, Multi Organ Transplant Program, Toronto, ON, Canada
Kollmann, Dagmar
Selzner, Nazia
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hlth Network, Toronto Gen Hosp, Dept Med, Toronto, ON, CanadaUniv Hlth Network, Toronto Gen Hosp, Dept Surg, Multi Organ Transplant Program, Toronto, ON, Canada
Selzner, Nazia
Selzner, Markus
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hlth Network, Toronto Gen Hosp, Dept Surg, Multi Organ Transplant Program, Toronto, ON, Canada
Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Gen Surg & Multiorgan Transplant Program, 585 Univ Ave,11 PMB 178, Toronto, ON M5G 2N2, CanadaUniv Hlth Network, Toronto Gen Hosp, Dept Surg, Multi Organ Transplant Program, Toronto, ON, Canada
机构:
Tulane Univ, Sch Med, Div Hepatopancreatobiliary & Abdominal Transplant, New Orleans, LA 70112 USATulane Univ, Sch Med, Div Hepatopancreatobiliary & Abdominal Transplant, New Orleans, LA 70112 USA
Vijay, Adarsh
Jeon, Hoonbae
论文数: 0引用数: 0
h-index: 0
机构:Tulane Univ, Sch Med, Div Hepatopancreatobiliary & Abdominal Transplant, New Orleans, LA 70112 USA
机构:Univ Paris Sud, Ctr Hepatobiliaire,Hop Paul Brousse, UPRES 3541,Assistance Publ Hop Paris, Format Rech Assoc Claude Bernard Virus & Transpla, F-94800 Villejuif, France
Samuel, D
Vallee, JCD
论文数: 0引用数: 0
h-index: 0
机构:Univ Paris Sud, Ctr Hepatobiliaire,Hop Paul Brousse, UPRES 3541,Assistance Publ Hop Paris, Format Rech Assoc Claude Bernard Virus & Transpla, F-94800 Villejuif, France
Vallee, JCD
Teicher, E
论文数: 0引用数: 0
h-index: 0
机构:Univ Paris Sud, Ctr Hepatobiliaire,Hop Paul Brousse, UPRES 3541,Assistance Publ Hop Paris, Format Rech Assoc Claude Bernard Virus & Transpla, F-94800 Villejuif, France
Teicher, E
Vittecoq, D
论文数: 0引用数: 0
h-index: 0
机构:Univ Paris Sud, Ctr Hepatobiliaire,Hop Paul Brousse, UPRES 3541,Assistance Publ Hop Paris, Format Rech Assoc Claude Bernard Virus & Transpla, F-94800 Villejuif, France